606966-64-7

Basic information

• Product Name: (3-{3-[4-(4-tert-butyl-phenoxy)-2-propyl-phenoxy]-propoxy}-phenyl)-hydroxy-acetic acid methyl ester
• CAS NO: 606966-64-7
• Molecular Weight: 506.639
• Mol File: 606966-64-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (3-{3-[4-(4-tert-butyl-phenoxy)-2-propyl-phenoxy]-propoxy}-phenyl)-hydroxy-acetic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (3-{3-[4-(4-tert-butyl-phenoxy)-2-propyl-phenoxy]-propoxy}-phenyl)-hydroxy-acetic acid methyl ester(606966-64-7)
• EPA Substance Registry System: (3-{3-[4-(4-tert-butyl-phenoxy)-2-propyl-phenoxy]-propoxy}-phenyl)-hydroxy-acetic acid methyl ester(606966-64-7)

Safety Data

• Hazardous Substances Data: 606966-64-7(Hazardous Substances Data)

Upstream product

• 39064-93-2 4-(4-(tert-butyl)phenoxy)phenol 
• 98-54-4 para-tert-butylphenol 
• 228579-15-5 methyl 3-(3-bromopropoxy)mandelate 
• 606966-82-9 4-(4-tert-butyl-phenoxy)-2-propyl-phenol 
• 606966-77-2 C₁₉H₂₂O₂ 
• 108934-20-9 4-(4-tert-butylphenoxy)benzaldehyde 
• 459-57-4 4-fluorobenzaldehyde 
• 90721-46-3 methyl 3-hydroxymadelate 

Relevant articles and documents

5-Aryl thiazolidine-2,4-diones: Discovery of PPAR dual α/γ agonists as antidiabetic agents

A novel series of 5-aryl thiazolidine-2,4-diones based dual PPARα/γ agonists was identified. A number of highly potent and orally bioavailable analogues were synthesized. Efficacy study results of some of these analogues in the db/db mice model of type 2 diabetes showed them superior to rosiglitazone in correcting hyperglycemia and hypertriglyceridemia.